InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: mfascuba post# 22602

Sunday, 08/19/2018 6:50:38 AM

Sunday, August 19, 2018 6:50:38 AM

Post# of 27551
From mfascuba:

So the question I have is, based on the latest press release and all of the speculation, press releases by competition, and bashing of this stock, can any competitor detect and quantify ?9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and 11-nor-9-carboxy-tetrahydrocannabinol in low concentrations and low flow rates?

If so, they are competition.


Maybe this link can shed more light on this mysterious subject:

In certain embodiments, the plurality of analysis substances includes cannabinoid and one or more metabolites of cannabinoids. Further, in certain embodiments, the cannabinoid includes tetrahydrocannabinol (THC) and further, wherein the one or more metabolites includes cannabinol (CBN), 11-Hydroxy-?9-tetrahydrocannabinol (11-OH-THC), or 11-nor-9-Carboxy-THC (THC-COOH)

patents.justia.com/patent/9970950


If you scroll down to the bottom where the "References" are located, you will find tons of written research targeting your concern. The references include multiple materials by Dr. Marilyn Huestis, and even lists Dr. Olof Beck.

The perceived "competitions" patent application is 76 pages in length. I don't think any of the patent applications by Cannabix are more than 5 to 10 pages in depth? Maybe simplicity is the mother of all inventions? Time will tell, and time is the enemy.

Chuuurch!

/////AMG

It's A Real Movie



Take Your Best Screenshot

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLOZF News